What does Insight Molecular Diagnostics Inc. (IMDX) do?

Insight Molecular Diagnostics Inc. (IMDX) is a publicly traded company in the Healthcare sector.

What sector does IMDX operate in?

Insight Molecular Diagnostics Inc. operates in the Healthcare, specifically within the In Vitro & In Vivo Diagnostic Substances industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find IMDX earnings analysis?

AlphaOS publishes an earnings intelligence page for Insight Molecular Diagnostics Inc. (IMDX) covering results, guidance context, and AI-assisted analysis. See /stocks/IMDX/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

IMDX

Insight Molecular Diagnostics Inc.

Healthcare · In Vitro & In Vivo Diagnostic Substances

$3.18Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Insight Molecular Diagnostics Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -54% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -54% YoY in Q2 FY2026

Pipeline evidence · 0d ago

IMDX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on IMDX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full IMDX earnings analysis

Reported figures for Insight Molecular Diagnostics Inc. — research only, not investment advice.

Revenue YoY: -53.9%

Latest Intelligence

Updated September 29, 2026

What happened recently for Insight Molecular Diagnostics Inc. (IMDX) — events, not interpretation.

Event: Reported Q2 2026 revenue -54% YoY.
Also: Last session September 28, 2026 at $3.18.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Insight Molecular Diagnostics Inc. (IMDX)

Healthcare · In Vitro & In Vivo Diagnostic Substances

Investment Snapshot above is the primary AlphaOS analysis for Insight Molecular Diagnostics Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: In Vitro & In Vivo Diagnostic Substances
Market cap:: $104.06M
Revenue:: $239,000

IMDX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Insight Molecular Diagnostics Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.